PlainRecalls
FDA Drug Low Class III Terminated

Pramipexole Dihydrochloride Tablets, 0.125 mg, 90-count tablets per bottle, Rx only, Manufactured in India by Sandoz Private Ltd., for Sandoz Inc., Princeton, NJ 08540, NDC 0781-5248-92

Reported: September 26, 2012 Initiated: September 12, 2012 #D-1678-2012

Product Description

Pramipexole Dihydrochloride Tablets, 0.125 mg, 90-count tablets per bottle, Rx only, Manufactured in India by Sandoz Private Ltd., for Sandoz Inc., Princeton, NJ 08540, NDC 0781-5248-92

Reason for Recall

Impurities/Degradation Products: An out of specification result for a known impurity of the product occurred during 12 month stability testing.

Details

Recalling Firm
Sandoz Incorporated
Units Affected
41,761bottles.
Distribution
Nationwide
Location
Broomfield, CO

Frequently Asked Questions

What product was recalled?
Pramipexole Dihydrochloride Tablets, 0.125 mg, 90-count tablets per bottle, Rx only, Manufactured in India by Sandoz Private Ltd., for Sandoz Inc., Princeton, NJ 08540, NDC 0781-5248-92. Recalled by Sandoz Incorporated. Units affected: 41,761bottles..
Why was this product recalled?
Impurities/Degradation Products: An out of specification result for a known impurity of the product occurred during 12 month stability testing.
Which agency issued this recall?
This recall was issued by the FDA Drug on September 26, 2012. Severity: Low. Recall number: D-1678-2012.